These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16259963)

  • 1. Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.
    Meczes EL; Azim-Araghi A; Ottley CJ; Pearson DG; Tilby MJ
    Biochem Pharmacol; 2005 Dec; 70(12):1717-25. PubMed ID: 16259963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
    Tilby MJ; Johnson C; Knox RJ; Cordell J; Roberts JJ; Dean CJ
    Cancer Res; 1991 Jan; 51(1):123-9. PubMed ID: 1703029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of a high-affinity monoclonal antibody specific for 7-(benzo[alpha]pyren-6-yl) guanine and its application in a competitive enzyme-linked immunosorbent assay.
    Casale GP; Rogan EG; Stack D; Devanesan P; Cavalieri EL
    Chem Res Toxicol; 1996 Sep; 9(6):1037-43. PubMed ID: 8870993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques.
    Fichtinger-Schepman AM; Dijt FJ; Bedford P; van Oosterom AT; Hill BT; Berends F
    IARC Sci Publ; 1988; (89):321-8. PubMed ID: 3198216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA adducts of cisplatin and carboplatin in tissues of cancer patients.
    Poirier MC; Egorin MJ; Fichtinger-Schepman AM; Yuspa SH; Reed E
    IARC Sci Publ; 1988; (89):313-20. PubMed ID: 3058599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
    Liedert B; Pluim D; Schellens J; Thomale J
    Nucleic Acids Res; 2006 Mar; 34(6):e47. PubMed ID: 16571898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
    Tilby MJ; McCartney H; Gould KA; O'Hare CC; Hartley JA; Hall AG; Golding BT; Lawley PD
    Chem Res Toxicol; 1998 Oct; 11(10):1162-8. PubMed ID: 9778312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ detection of acetylaminofluorene-DNA adducts in human cells using monoclonal antibodies.
    Iwamoto TA; Kobayashi N; Imoto K; Yamamoto A; Nakamura Y; Yamauchi Y; Okumura H; Tanaka A; Hanaoka F; Shibutani S; Miyagawa S; Mori T
    DNA Repair (Amst); 2004 Nov; 3(11):1475-82. PubMed ID: 15380103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts.
    Beljanski V; Villanueva JM; Doetsch PW; Natile G; Marzilli LG
    J Am Chem Soc; 2005 Nov; 127(45):15833-42. PubMed ID: 16277526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
    Veal GJ; Dias C; Price L; Parry A; Errington J; Hale J; Pearson AD; Boddy AV; Newell DR; Tilby MJ
    Clin Cancer Res; 2001 Aug; 7(8):2205-12. PubMed ID: 11489793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases.
    Chválová K; Sari MA; Bombard S; Kozelka J
    J Inorg Biochem; 2008 Feb; 102(2):242-50. PubMed ID: 17961652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative profiling of in vivo generated cisplatin-DNA adducts using different isotope dilution strategies.
    García Sar D; Montes-Bayón M; Blanco González E; Sierra LM; Aguado L; Comendador MA; Koellensperger G; Hann S; Sanz-Medel A
    Anal Chem; 2009 Dec; 81(23):9553-60. PubMed ID: 19886652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.
    Reed E; Gupta-Burt S; Litterst CL; Poirier MC
    Carcinogenesis; 1990 Dec; 11(12):2117-21. PubMed ID: 1979937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GA and AG sequences of DNA react with cisplatin at comparable rates.
    Monjardet-Bas V; Bombard S; Chottard JC; Kozelka J
    Chemistry; 2003 Oct; 9(19):4739-45. PubMed ID: 14566881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a monoclonal antibody recognizing benzo[c]phenanthrenediol epoxide-DNA adducts: application to immunohistochemical detection of DNA damage.
    Zhang YJ; Geacintov NE; Santella RM
    Chem Res Toxicol; 1997 Sep; 10(9):948-52. PubMed ID: 9305575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
    Sundquist WI; Lippard SJ; Stollar BD
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody recognition of melphalan adducts characterized using immobilized DNA: enhanced alkylation of G-Rich regions in cells compared to in vitro.
    McCartney H; Martin AM; Middleton PG; Tilby MJ
    Chem Res Toxicol; 2001 Jan; 14(1):71-81. PubMed ID: 11170510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.